The vaccines are indicated for active immunization against influenza disease caused by virus subtypes A and type B present in the vaccine. The vaccines are indicated for active immunization against ...

Jet injector device delivers single dose of injectable flu vaccine without a needle KING OF PRUSSIA, Penn. / GOLDEN, Colo. – [August 19, 2014] – PharmaJet® Inc., the developer of a needle-free ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved AFLURIA QUADRIVALENT (Influenza Vaccine) for use in people five years of age ...

CSL Biotherapies announced that it has finalized shipment of 11 million doses of Afluria (trivalent, inactivated, “split virus” influenza vaccine [Types A and B]) vaccine for the 2013–2014 season.

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Phase III pivotal study findings in the journal Vaccine showed that two formulations of CSL Biotherapies' influenza virus vaccine Afluria ® elicited an immune ...

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from ...

* Seqirus receives FDA approval of afluria quadrivalent (influenza vaccine) for people five years of age and older in the U.S. Sign up here. * Says ‍both afluria quadrivalent and afluria , are ...

Afluria Quadrivalent is the latest example of how Seqirus is delivering on its promise to help improve public health around the world." Seqirus has earlier announced the availability of Fluad ...

Mar. 23 -- FRIDAY, Sept. 28 (HealthDay News) -- With flu season fast approaching, U.S. health officials announced Friday the approval of a new vaccine intended for people 18 and older. The vaccine, ...

KING OF PRUSSIA, Pa., July 13, 2015 /PRNewswire/ -- bioCSL Inc. announced today it has begun shipping AFLURIA, Influenza Vaccine in advance of the 2015-2016 influenza season. In support of improving ...

KING OF PRUSSIA, Pa. — BioCSL on Tuesday announced that it has started shipping the seasonal influenza vaccine Afluria for the 2014-15 flu season. Providers in the United States who ordered Afluria ...

If AFLURIA is administered to immunocompromised persons, including those receiving immunosuppressive therapy, the immune response may be diminished. AFLURIA should be given to a pregnant woman only if ...